Annual ROA
-26.33%
+18.88%+41.76%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual return on assets is -26.33%, with the most recent change of +18.88% (+41.76%) on December 31, 2023.
- During the last 3 years, ELVN annual ROA has fallen by -11.85% (-81.84%).
- ELVN annual ROA is now -81.84% below its all-time high of -14.48%, reached on December 1, 2020.
Performance
ELVN ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-27.33%
-0.08%-0.29%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly return on assets is -27.33%, with the most recent change of -0.08% (-0.29%) on September 30, 2024.
- Over the past year, ELVN quarterly ROA has dropped by -0.28% (-1.04%).
- ELVN quarterly ROA is now -269.32% below its all-time high of -7.40%, reached on December 1, 2021.
Performance
ELVN Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
ELVN ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.8% | -1.0% |
| 3 y3 years | -81.8% | +0.6% |
| 5 y5 years | -81.8% | +0.6% |
ELVN ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.6% | +41.8% | -269.3% | +36.8% |
| 5 y | 5-year | -81.8% | +41.8% | -269.3% | +36.8% |
| alltime | all time | -81.8% | +41.8% | -269.3% | +36.8% |
Enliven Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -27.33%(+0.3%) |
| Jun 2024 | - | -27.25%(+0.7%) |
| Mar 2024 | - | -27.05%(+7.4%) |
| Dec 2023 | -26.33%(-41.8%) | -25.18%(-3.3%) |
| Sep 2023 | - | -26.04%(-3.3%) |
| Jun 2023 | - | -26.94%(-2.0%) |
| Mar 2023 | - | -27.50%(-36.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -45.21%(+107.1%) | -43.27%(+21.0%) |
| Sep 2022 | - | -35.77%(+56.2%) |
| Jun 2022 | - | -22.90%(+52.2%) |
| Mar 2022 | - | -15.05%(+103.4%) |
| Dec 2021 | -21.83%(+50.8%) | - |
| Dec 2021 | - | -7.40% |
| Dec 2020 | -14.48% | - |
FAQ
- What is Enliven Therapeutics annual return on assets?
- What is the all time high annual ROA for Enliven Therapeutics?
- What is Enliven Therapeutics annual ROA year-on-year change?
- What is Enliven Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly ROA year-on-year change?
What is Enliven Therapeutics annual return on assets?
The current annual ROA of ELVN is -26.33%
What is the all time high annual ROA for Enliven Therapeutics?
Enliven Therapeutics all-time high annual return on assets is -14.48%
What is Enliven Therapeutics annual ROA year-on-year change?
Over the past year, ELVN annual return on assets has changed by +18.88% (+41.76%)
What is Enliven Therapeutics quarterly return on assets?
The current quarterly ROA of ELVN is -27.33%
What is the all time high quarterly ROA for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly return on assets is -7.40%
What is Enliven Therapeutics quarterly ROA year-on-year change?
Over the past year, ELVN quarterly return on assets has changed by -0.28% (-1.04%)